Privacy AI
Regulatory

Health data compliance, handled.

Tell us what you need. We'll tell you what it takes and how long, before you commit.

Contact us

Summary

Contact us
The Federal Trade Commission announced it has finalized changes to the Health Breach Notification Rule (HBNR) that will strengthen and modernize the rule by clarifying its applicability to health apps and other similar technologies and expanding the information that covered entities must provide to consumers when notifying them of a breach of their health data.

Modifications to the regulation

  1. Updating Definitions: The Commission has updated several definitions to emphasize the applicability of the final rule to health apps and similar technologies not governed by HIPAA. This includes altering the definition of “PHR identifiable health information” and introducing new definitions for “covered health care provider” and “health care services or supplies.”
  2. Specifying Security Breaches: The rule now specifies that a "breach of security" encompasses unauthorized access to identifiable health information, whether through a data security incident or unauthorized disclosure.
  3. Amending the Definition of PHR Related Entity: The definition of “PHR related entity” has been refined in two significant ways relevant to the rule’s scope. It now specifies that the rule applies to entities that provide products and services via the online services of personal health record vendors, including mobile apps. It also restricts the definition to entities that access or transmit unsecured PHR identifiable health information to a personal health record.
  4. Clarifying Information from Multiple Sources: The rule clarifies the criteria for a personal health record to incorporate PHR identifiable health information from various sources.
  5. Enhancing Electronic Notifications: The final rule permits broader use of email and other electronic methods for sending clear and effective breach notifications to consumers.
  6. Broadening Notice Requirements: The content required in consumer notifications has been expanded. Notices must now include either the name or a description of any third parties who obtained unsecured PHR identifiable health information due to a security breach, especially when revealing the full name poses a risk.
  7. Adjusting Notification Timelines: The final rule changes the timing for notifying the FTC about breaches impacting 500 or more individuals. Covered entities must now notify the FTC concurrently with affected individuals, doing so promptly and no later than 60 calendar days after identifying a breach.
  8. Improving Clarity and Compliance: The final rule also includes modifications to enhance clarity and facilitate compliance.

The rule takes effect 60 days after its announcement in the Federal Register.

Click to read more

Contact us

FAQs

Our frequently questions

No items found.

Seamus Larroque

CDPO / CPIM / ISO 27005 Certified

Find out how iliomad can help your company.

[Map placeholder]
Only visible in production
38.709099
-39.182035
1.6
6d17042a3425c5b3
Your message has been received!
We'll get back to you as soon as possible.
Something went wrong, please try again.
Home

Discover our latest articles

View All Blog Posts
Illustration of the CNIL MR-001 framework applied to a clinical trial data compliance workflow in France, showing patient data flow and security controls
September 7, 2026
GDPR
Regulation
Guideline
Regulations & Guidelines

MR-001 CNIL: what clinical trial sponsors must know about French health data compliance

Understand MR-001 CNIL obligations for clinical trial sponsors in France, from Article 32 security requirements to breach notification and cross-border data transfers.

A clinical trial coordinator reviewing an informed consent form alongside a data governance checklist, representing ICF boilerplate review and open-access database disclosure compliance
September 4, 2026
Guideline
EU Privacy Law
Regulations & Guidelines
Clinical Trials
United-Kingdom

ICF Boilerplate and Open-Access Database Disclosures: What Clinical Trial Sponsors Must Know

Learn how US site ICF boilerplate on commercial products and open-access genetic databases affects sponsor data governance, Common Rule compliance and GDPR obligations.

Abstract digital network graphic representing data protection, clinical trial compliance and cybersecurity themes for the iliomad weekly digest
September 3, 2026
Regulations & Guidelines
GDPR
Data Breach & Cybersecurity
LLMS

iliomad Weekly Digest: DPO Conflicts, Bulk Data Rules, Healthcare Cyber Incidents and AI Transparency

This week: CNIL on DPO conflicts of interest, DOJ bulk data rule for life sciences, wave of healthcare ransomware attacks, Uber's €825m GDPR fine and AI disclosure demands.